698
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Association of ambulatory arterial stiffness index with sEPCR in newly diagnosed hypertensive patients

, , , , , , , & show all
Pages 1409-1413 | Received 23 Jan 2015, Accepted 14 Jul 2015, Published online: 31 Aug 2015

References

  • Li Y, Wang JG, Dolan E, et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension. 2006;47(3):359–364
  • Dolan E, Li Y, Thijs L, et al. Ambulatory arterial stiffness index: Rationale and methodology. Blood Press Monit. 2006;11:103–105
  • Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol. 2007;34(7):647–651
  • Aznaouridis K, Vlachopoulos C, Protogerou A, et al. Ambulatory systolic–diastolic pressure regression index as a predictor of clinical events: A meta-analysis of longitudinal studies. Stroke. 2012;43(3):733–739
  • Kollias A, Stergiou GS, Dolan E, O'Brien E. Ambulatory arterial stiffness index: A systematic review and meta-analysis. Atherosclerosis. 2012;224(2):291–301
  • Kips JG, Vermeersch SJ, Reymond P, et al. Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens. 2012;30(3):574–580
  • Chirinos JA. Arterial stiffness: Basic concepts and measurement techniques. J Cardiovasc Transl Res. 2012;5(3):243–255
  • Laszik Z, Mitro A, Taylor FB Jr, et al. Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway. Circulation. 1997;96(10):3633–3640
  • Van de Wouwer M, Collen D, Conway EM. Thrombomodulin–protein C-EPCR system: Integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol. 2004;24(8):1374–1383
  • Esmon CT. The endothelial protein C receptor. Curr Opin Hematol. 2006;13:382–385
  • Liaw PC, Neuenschwander PF, Smirnov MD, et al. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem. 2000;275:5447–5452
  • Uitte de Willige S, Van Marion V, Rosendaal FR, et al. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost. 2004;2:1305–1310
  • Ulu A, Gunal D, Tiras S, et al. EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients. Thromb Res. 2007;120(1):47–52
  • Tanalp AC, Oduncu V, Erkol A, et al. Soluble endothelial protein C receptor levels and protein C activity in patients with acute ST-segment elevation myocardial infarction. Coron Artery Dis. 2013;24(3):209–216
  • Varughese GI, Lip GY. Is hypertension a prothrombotic state? Curr Hypertens Rep. 2005;7(3):168–173
  • Kakar P, Lip GY. Hypertension: Endothelial dysfunction, the prothrombotic state and antithrombotic therapy. Expert Rev Cardiovasc Ther. 2007;5(3):441–450
  • Regnault V, Perret-Guillaume C, Kearney-Schwartz A, et al. Tissue factor pathway inhibitor: A new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women. Arterioscler Thromb Vasc Biol. 2011;31(5):1226–1232
  • Wykretowicz J, Guzik P, Krauze T, et al. Fibrinogen and D-dimer in contrasting relation with measures of wave reflection and arterial stiffness. Scand J Clin Lab Invest. 2012;72(8):629–634
  • Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: The JNC 7 report. JAMA. 2003;289:2560–2572
  • Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612
  • Schillaci G, Parati G. Ambulatory arterial stiffness index: Merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens. 2008;26:182–185
  • Laugesen E, Erlandsen M, Knudsen ST, et al. Ambulatory arterial stiffness index: A composite index reflecting arterial stiffness, blood pressure variability and patients’ diurnal cycle. J Hypertens. 2011;29:2278–2279
  • Hansen TW, Staessen JA, Torp-Pedersen C, et al. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens. 2006;24:2247–2253
  • Leoncini G, Ratto E, Viazzi F, et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension. 2006;48:397–403
  • Ben-Dov IZ, Gavish B, Kark JD, et al. A modified ambulatory arterial stiffness index is independently associated with all-cause mortality. J Hum Hypertens. 2008;22:761–766
  • Catena C, Bernardi S, Sabato N, et al. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. Nutr Metab Cardiovasc Dis. 2013;23(4):389–393
  • Chen H, Hua Q, Hou H. Association of hemoglobin with ambulatory arterial stiffness index in untreated essential hypertensive patients without anemia. Intern Med. 2011;50(22):2759–2765
  • Gu JM, Katsuura Y, Ferrell GL, et al. Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood. 2000;95:1687–1693
  • Kurosawa S, Stearns-Kurosawa DJ, Carson CW, et al. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: Lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood. 1998;91:725–727
  • Saposnik B, Peynaud-Debayle E, Stepanian A, et al. Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: A marker of endothelial activation/damage? Thromb Res. 2012;129(2):152–157
  • Lip GYH, Blann AD, Edmunds E, et al. Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension. Blood Coagul Fibrinolysis. 2002;13:35–41
  • Kotliar C, Kempny P, Gonzalez S, et al. Lack of RAAS inhibition by high-salt intake is associated with arterial stiffness in hypertensive patients. J Renin Angiotensin Aldosterone Syst. 2014;15(4):498–504
  • Remková A, Kratochvíl'ová H, Durina J. Impact of the therapy by renin–angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension. J Hum Hypertens. 2008;22(5):338–345
  • Aroor AR, Demarco VG, Jia G, et al. The role of tissue renin–angiotensin–aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne). 2013;4:161
  • Mahmud A, Feely J. Arterial stiffness and the renin–angiotensin–aldosterone system. J Renin Angiotensin Aldosterone Syst. 2004;5(3):102–108
  • Wang X, Du Y, Fan L, et al. Relationships between HDL-C, hs-CRP, with central arterial stiffness in apparently healthy people undergoing a general health examination. PLoS One. 2013;8(12):e81778
  • Miao DM, Ye P, Xiao WK, et al. Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension. J Clin Hypertens (Greenwich). 2011;13(10):710–715

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.